Clinical Trial Update: Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describing the use of FDG-PET/CT to assess response in bone-dominant metastatic breast cancer (FEATURE study). The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING